Late allograft loss in kidney transplant recipients remains a common problem and is
associated with high mortality and morbidity. The management of patients with a failed …

Background IgA nephropathy may recur in patients receiving kidney transplantation due to
IgA nephropathy induced renal failure. The risk factors for recurrence are still at issue. The …

A high intrapatient variability (IPV) in tacrolimus exposure is a risk factor for poor long‐term
outcomes after kidney transplantation. The main objective of this trial was to investigate …

Background Advances in renal transplantation have improved graft survival. However, many
patients experience graft failure due to chronic renal allograft nephropathy. Although renal …

Objectives Kidney transplant (KTx) recipients with IgAN as primary disease, were compared
with recipients with other causes of renal failure, in terms of long-term outcomes. Methods …

Background: The data on long-term outcomes of posttransplant immunoglobulin A
nephropathy (IgAN) are confounding and vary with geography and ethnicity worldwide. We …

As one of the most common types of primary glomerulonephritis, IgA nephropathy (IgAN) is
often characterized by the immunoprecipitation of IgA1 in mesangial area. In clinical terms …

IgA nephropathy (IgAN), defined by dominant immunoglobulin A glomerular deposits, is the
commonest glomerular disease in children presenting with microscopic hematuria. Its …

The term immunoglobulin A nephropathy (IgA nephropathy or IgA N) refers to a primary
glomerular disease characterized by the dominant or co-dominant, diffuse, and generalized …

Introducción: La realización de un segundo trasplante renal es la mejor opción de
tratamiento de reemplazo de la función de este órgano para aquellos enfermos que han …